{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2819"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2819","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Impact of state-led surveillance programs on neonatal abstinence syndrome","abstract":"Introduction: Neonatal Abstinence Syndrome (NAS) has been costly for the healthcare system, for every 24 minutes a baby was diagnosed in 2020. Uniform programs to diagnosis, track and prevent NAS have not been implemented previously. The NCBDDD worked with 6 states to implement a uniform surveillance program. By tracking the NAS incidence rate, the Apgar scores of infants with NAS, the length of stay for those infants, the cost of care for those infants and the percentage of mothers of infants with NAS were participating in Medication Assisted Treatment the effectiveness of the surveillance programs may be assessed. Methodology: This study utilized a literature review and a semi-structured interview. Three databases were used to collect 347 total sources. These sources were reviewed and reduced to 30 total sources that were used in the written research. Of these, 10 sources were used in the results section. Purpose of the Study: The purpose of this research was to identify the impact of NCBDDD surveillance programs on Neonatal Abstinence Syndrome incidence rates, Apgar scores reported for infants with NAS, length of stay, cost of care and the percentages of mothers who were treated with Medication Assisted Treatment while pregnant. Results: The research showed that NCBDDD surveillance programs were not associated with decreases in NAS incidence rates, length of stay, cost of care, or an increase in Apgar scores or the percentage of mothers who were treated with Medicare Assisted Treatment while pregnant.","abstract_html":"Introduction: Neonatal Abstinence Syndrome (NAS) has been costly for the healthcare system, for every 24 minutes a baby was diagnosed in 2020. Uniform programs to diagnosis, track and prevent NAS have not been implemented previously. The NCBDDD worked with 6 states to implement a uniform surveillance program. By tracking the NAS incidence rate, the Apgar scores of infants with NAS, the length of stay for those infants, the cost of care for those infants and the percentage of mothers of infants with NAS were participating in Medication Assisted Treatment the effectiveness of the surveillance programs may be assessed. Methodology: This study utilized a literature review and a semi-structured interview. Three databases were used to collect 347 total sources. These sources were reviewed and reduced to 30 total sources that were used in the written research. Of these, 10 sources were used in the results section. Purpose of the Study: The purpose of this research was to identify the impact of NCBDDD surveillance programs on Neonatal Abstinence Syndrome incidence rates, Apgar scores reported for infants with NAS, length of stay, cost of care and the percentages of mothers who were treated with Medication Assisted Treatment while pregnant. Results: The research showed that NCBDDD surveillance programs were not associated with decreases in NAS incidence rates, length of stay, cost of care, or an increase in Apgar scores or the percentage of mothers who were treated with Medicare Assisted Treatment while pregnant.","abstract_has_math":false,"creators":["Lewis, Patricia"],"institution":null,"degree_name":"Healthcare Administration","degree_level":"Research Paper","degree_discipline":"College of Business","degree_department":null,"school":null,"contributors":["Alberto Coustasse"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:01Z","subjects":["Business","Business Administration, Management, and Operations","Health and Medical Administration","Medicine and Health Sciences","Neonatal Abstinence Syndrome","NAS","NCBDDD surveillance programs","Surveillance","length of stay","Apgar score","cost","MAT","Medication Assisted Treatment"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1814","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1814","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2819","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alberto Coustasse"]},{"key":"dc:creator","label":"Author","values":["Lewis, Patricia"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-08-29T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Business"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Research Paper"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Healthcare Administration"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Business","Business Administration, Management, and Operations","Health and Medical Administration","Medicine and Health Sciences","Neonatal Abstinence Syndrome","NAS","NCBDDD surveillance programs","Surveillance","length of stay","Apgar score","cost","MAT","Medication Assisted Treatment"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1814"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction: Neonatal Abstinence Syndrome (NAS) has been costly for the healthcare system, for every 24 minutes a baby was diagnosed in 2020. Uniform programs to diagnosis, track and prevent NAS have not been implemented previously. The NCBDDD worked with 6 states to implement a uniform surveillance program. By tracking the NAS incidence rate, the Apgar scores of infants with NAS, the length of stay for those infants, the cost of care for those infants and the percentage of mothers of infants with NAS were participating in Medication Assisted Treatment the effectiveness of the surveillance programs may be assessed. Methodology: This study utilized a literature review and a semi-structured interview. Three databases were used to collect 347 total sources. These sources were reviewed and reduced to 30 total sources that were used in the written research. Of these, 10 sources were used in the results section. Purpose of the Study: The purpose of this research was to identify the impact of NCBDDD surveillance programs on Neonatal Abstinence Syndrome incidence rates, Apgar scores reported for infants with NAS, length of stay, cost of care and the percentages of mothers who were treated with Medication Assisted Treatment while pregnant. Results: The research showed that NCBDDD surveillance programs were not associated with decreases in NAS incidence rates, length of stay, cost of care, or an increase in Apgar scores or the percentage of mothers who were treated with Medicare Assisted Treatment while pregnant."]},{"key":"dc:title","label":"Title","values":["Impact of state-led surveillance programs on neonatal abstinence syndrome"]}]}],"canonical_facts":{"dc:contributor":["Alberto Coustasse"],"dc:creator":["Lewis, Patricia"],"dc:date.available":["2023-08-29T07:00:00Z"],"dc:date.created":["2023-01-01T08:00:00Z"],"dc:description.abstract":["Introduction: Neonatal Abstinence Syndrome (NAS) has been costly for the healthcare system, for every 24 minutes a baby was diagnosed in 2020. Uniform programs to diagnosis, track and prevent NAS have not been implemented previously. The NCBDDD worked with 6 states to implement a uniform surveillance program. By tracking the NAS incidence rate, the Apgar scores of infants with NAS, the length of stay for those infants, the cost of care for those infants and the percentage of mothers of infants with NAS were participating in Medication Assisted Treatment the effectiveness of the surveillance programs may be assessed. Methodology: This study utilized a literature review and a semi-structured interview. Three databases were used to collect 347 total sources. These sources were reviewed and reduced to 30 total sources that were used in the written research. Of these, 10 sources were used in the results section. Purpose of the Study: The purpose of this research was to identify the impact of NCBDDD surveillance programs on Neonatal Abstinence Syndrome incidence rates, Apgar scores reported for infants with NAS, length of stay, cost of care and the percentages of mothers who were treated with Medication Assisted Treatment while pregnant. Results: The research showed that NCBDDD surveillance programs were not associated with decreases in NAS incidence rates, length of stay, cost of care, or an increase in Apgar scores or the percentage of mothers who were treated with Medicare Assisted Treatment while pregnant."],"dc:identifier":["https://mds.marshall.edu/etd/1814"],"dc:subject":["Business","Business Administration, Management, and Operations","Health and Medical Administration","Medicine and Health Sciences","Neonatal Abstinence Syndrome","NAS","NCBDDD surveillance programs","Surveillance","length of stay","Apgar score","cost","MAT","Medication Assisted Treatment"],"dc:title":["Impact of state-led surveillance programs on neonatal abstinence syndrome"],"thesis:degree_discipline":["College of Business"],"thesis:degree_level":["Research Paper"],"thesis:degree_name":["Healthcare Administration"]},"updated_at":"2026-11-21T19:58:01Z"}